Generic competition · all medicines · read 12 November 2026
Is there a generic of Fluticasone Propionate, and who makes it?
Fluticasone Propionate appears in 6 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 10 generic makers listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came between 6.1 and 29.9 years after the first brand approval. This is the Orange Book's listing, not a forecast.
Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.
- Fluticasone Propionate appears in 6 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 10 generic makers listed as marketed across them.
- 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
- Where both are dated, the first generic approval came between 6.1 and 29.9 years after the first brand approval.
- Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.
Spray, Metered, Nasal
Four or more generic makers listed
Brand listed as marketed: Flonase Allergy Relief and Xhance. 6 generic makers with 10 generic products listed as marketed; the first generic approval is dated 22 February 2006.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Hikma Pharmaceuticals Usa Inc | 22 February 2006 | 2 |
| Apotex Inc | 12 September 2007 | 2 |
| Chartwell Rx Sciences Llc | 9 January 2012 | 1 |
| Aurobindo Pharma Ltd | 10 May 2024 | 1 |
| Rubicon Research Ltd | 5 June 2025 | 2 |
| Glenmark Specialty Sa | 16 March 2026 | 2 |
Patents and exclusivities still listed
- 15 March 2027Exclusivity I-940 Xhance
- 4 April 2031Patent 12083270
- 23 February 2036Patent 11554229
- 23 February 2036Patent 12616806
Powder, Inhalation
Brand listed, no generic listed as marketed
Brand listed as marketed: Flovent Diskus 100, Flovent Diskus 250 and Flovent Diskus 50. No generic is listed as marketed.
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Aerosol, Metered, Inhalation
One to three generic makers listed
Brand listed as marketed: Flovent Hfa. 1 generic maker with 1 generic product listed as marketed; the first generic approval is dated 3 March 2026.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Glenmark Specialty Sa | 3 March 2026 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Cream, Topical
Four or more generic makers listed
Every brand product here is listed as discontinued. 4 generic makers with 4 generic products listed as marketed; the first generic approval is dated 14 May 2004.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Encube Ethicals Private Ltd | 14 May 2004 | 1 |
| Fougera Pharmaceuticals Inc | 14 May 2004 | 1 |
| Padagis Israel Pharmaceuticals Ltd | 14 May 2004 | 1 |
| Cosette Pharmaceuticals Nc Laboratories Llc | 30 June 2006 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Ointment, Topical
One to three generic makers listed
Every brand product here is listed as discontinued. 2 generic makers with 2 generic products listed as marketed; the first generic approval is dated 14 May 2004.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | 14 May 2004 | 1 |
| Cosette Pharmaceuticals Nc Laboratories Llc | 3 March 2006 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Lotion, Topical
One to three generic makers listed
Every brand product here is listed as discontinued. 1 generic maker with 1 generic product listed as marketed; the first generic approval is dated 2 May 2011.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | 30 July 2013 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.
Where can you go from this result?
Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.